Insiders Bullish on Certain Holdings of XBI

A look at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows an impressive 11.8% of holdings on a weighted basis have experienced insider buying within the past six months.

START SLIDESHOW:
10 ETFs With Stocks That Insiders Are Buying »

Inovio Pharmaceuticals Inc. ( INO), which makes up 1.52% of the SPDR S&P Biotech ETF (XBI), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $17,539,872 worth of INO, making it the #11 largest holding. The table below details the recent insider buying activity observed at INO:

INO — last trade: $10.32 — Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
08/12/2014 Niranjan Sardesai Chief Operating Officer 2,550 $8.70 $22,185.00
08/20/2014 Morton Collins Director 40,600 $9.74 $395,391.32
08/21/2014 Morton Collins Director 8,000 $10.01 $80,089.60

And Raptor Pharmaceuticals Corp. ( RPTP), the #41 largest holding among components of the SPDR S&P Biotech ETF (XBI), shows 2 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $14,781,105 worth of RPTP, which represents approximately 1.28% of the ETF's total assets at last check. The recent insider buying activity observed at RPTP is detailed in the table below:

RPTP — last trade: $11.46 — Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
05/13/2014 Georgia Erbez Chief Financial Officer 16,100 $7.90 $127,190.00
05/30/2014 Llew Keltner Director 100 $8.37 $837.00

More from Stocks

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

Here's Why General Electric's Stock Isn't Falling Off a Cliff After Earnings

Here's Why General Electric's Stock Isn't Falling Off a Cliff After Earnings

What General Electric Shareholders Should Do Now

What General Electric Shareholders Should Do Now

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Will Tesla Stock Tumble 33% to $195?

Will Tesla Stock Tumble 33% to $195?